Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study

Berglin, Ewa; Dahlqvist, S. Rantapää

doi:10.3109/03009742.2013.776103

Cited by 35 publications

(27 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nine full articles9–13 20–22 41 and 11 meeting abstracts24 25 27 29 30 32–35 37 38 were on patients with early arthritis (disease duration < 24 months); four articles8 17 18 42 and three abstracts23 26 40 on heterogeneous cohorts of patients ‘with joint symptoms’ (including tenderness, pain, loss of movement, or morning stiffness with or without swelling; see table 1); one article14 and two abstracts31 39 on cohorts of patients with undifferentiated arthritis; three articles15 16 19 and two abstracts25 36 on cohorts of patients with RA according to the 1987 ACR criteria.…”

Section: Resultsmentioning

confidence: 99%

“…These studies used different reference standards for assessing the performance of the 2010 criteria (table 1): initiation of methotrexate treatment8–10 13 20 24 37 41; initiation of any disease modifying antirheumatic drug (DMARD)10 13 20 22 38 41; diagnosis of RA by a specialist24 27 29 30 32 34 35 40–42; diagnosis by an office-based rheumatologist plus initiation of DMARD therapy17 21; confirmed RA diagnosis after 20 years16; persistent disease (definition see table 1) after one,8 five20 or 1010 years; diagnosis of RA by experts plus fulfilment of 1987 ACR criteria 18. Some publications offered more than one reference standard for analysis.…”

Section: Resultsmentioning

confidence: 99%

“…Mean sensitivities and specificities (±SDs) were 0.68±0.17 and 0.69+0.15 when performed within patients with any joint symptoms , with or without presence of arthritis (four full articles,8 17 18 42 three meeting abstracts23 26 40); they were 0.79±0.1 and 0.73±0.11 when performed within arthritis patients only (four full articles,11 17 21 22 five meeting abstracts27 32–34 38); mean sensitivity was 0.78±0.10 and mean specificity 0.68±0.07 for performance within arthritis patients in whom synovitis was not better explained by another disease (five full articles,10 12 17 20 22 two meeting abstracts24 30); and finally 0.78±0.13 and 0.59±0.16 within arthritis patients in whom synovitis was not better explained by another disease, and considering x-rays (full algorithm) : (six full articles,9 11 13 20 21 41 one meeting abstract35) (figure 1). …”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review

et al. 2013

View full text Add to dashboard Cite

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review

et al. 2013

View full text Add to dashboard Cite

show abstract

“…The diagnosis of RA was validated by an experienced rheumatologist and based on the recognized criteria proposed either by EULAR or ACR (> 6 criteria) [13]. The type of treatment introduced at baseline and during follow-up was also recorded.…”

Section: Clinical Assessmentmentioning

confidence: 99%

Ultrasound can be useful to predict an evolution towards rheumatoid arthritis in patients with inflammatory polyarthralgia without anticitrullinated antibodies

et al. 2017

View full text Add to dashboard Cite

“…The sensitivity of these criteria was measured recently and found to be higher than their precursors from 1987 while having a lower specificity [11]. A clinically wide use of those current criteria is one of the reasons for a different clinical presentation of RA resulting in an earlier diagnosis with much less radiological joint alterations.…”

Section: Diagnosismentioning

confidence: 98%

The current relevance and use of prednisone in rheumatoid arthritis

Krasselt¹,

Baerwald

2014

Expert Review of Clinical Immunology

View full text Add to dashboard Cite

Prednisone is an old and very valuable drug in clinical use for over 60 years by now. It is well known by physicians and widely used for different kinds of inflammatory states including rheumatoid arthritis (RA). Clinical trials during the last 20 years have changed its clinical use, particularly with regards to dosage. Today, rheumatologists are treating their patients much more likely over a long period of time using a low-dose scheme. The effectiveness and safety of this low-dose use is the objective of the current clinical research and shall be enlightened in this drug profile. It is also featuring current knowledge about the value of modified-release prednisone with regards to the just published results of the 2nd Circadian Administration of Prednisone in Rheumatoid Arthritis trial. Moreover, the mechanisms of action of prednisone and its relatives will be summed up.

show abstract

Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study

Abstract: Compared with the 1987 ACR criteria, the 2010 ACR/EULAR criteria have higher sensitivity but lower specificity, especially in patients aged ≥ 60 years. The 1987 ACR criteria are suggested to predict a more erosive disease.

Cited by 35 publications

References 13 publications

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review

Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review

Ultrasound can be useful to predict an evolution towards rheumatoid arthritis in patients with inflammatory polyarthralgia without anticitrullinated antibodies

The current relevance and use of prednisone in rheumatoid arthritis

Contact Info

Product

Resources

About